Litcius/Paper detail

Statin use and 30‐day mortality in patients with acute symptomatic pulmonary embolism

Carmine Siniscalchi, Alfonso Muriel, José Maria Suriñach Caralt, Behnood Bikdeli, David Jiménez, José Luís Lobo, Cristina Amado, Aída Gil‐Díaz, Egidio Imbalzano, Manuel Monréal, Manuel Monréal, Paolo Prandoni, Benjamin Brenner, Dominique Farge, Raquel Barba, Pierpaolo Di Micco, Laurent Bertoletti, Sebastian Schellong, Inna Tzoran, Abílio Reis, Marijan Bosevski, Henri Bounameaux, Radován Malý, Peter Verhamme, Joseph A. Caprini, My Bui

2022Journal of Thrombosis and Haemostasis20 citationsDOI

Topics & Concepts

MedicineStatinInternal medicinePulmonary embolismOdds ratioConfidence intervalAntithromboticHazard ratioClinical endpointProportional hazards modelRandomized controlled trialVenous Thromboembolism Diagnosis and ManagementLipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism
Statin use and 30‐day mortality in patients with acute symptomatic pulmonary embolism | Litcius